References
- Vizintin Z, Lukac M, Kazic M, Tettamanti M. Erbium laser in gynecology. Climacteric 2015;18(Suppl 1):4–8
- Blaganje M, Šćepanović D, Žgur L, Verdenik I, Pajk F, Lukanović A. Non-ablative Er:YAG laser therapy effect on stress urinary incontinence related to quality of life and sexual function: A randomized controlled trial. Eur J Obstet Gynecol Reprod Biol 2018;224:153–8
- Gaviria JP, Korosec B, Fernandez J, Montero G. Up to 3-year follow-up of patients with vaginal relaxation syndrome participating in laser vaginal tightening. J Laser Health Acad 2016;2016:6–11
- Gaspar A, Brandi H, Gomez V, Luque D. Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause. Lasers Surg Med 2017;49:160–8
- Bizjak-Ogrinc U, Senčar S. Non-ablative vaginal erbium YAG laser for the treatment of cystocele. Ital J Gynaecol Obstet 2017;29:19–25
- Hayashi K, Thabit G, Massa KL, et al. The effect of thermal heating on the length and histologic properties of the glenohumeral joint capsule. Am J Sports Med 1997;25:107–12
- Lapii GA, Yakovleva AY, Neimark AI. Structural reorganization of the vaginal mucosa in stress urinary incontinence under conditions of Er:YAG laser treatment. Bull Exp Biol Med 2017;162:510–14
- Lukac M, Gaspar A, Bajd F. Dual tissue regeneration: non-ablative resurfacing of soft tissues with FotonaSmooth® mode Er:YAG laser. J Laser Health Acad 2018;2018:1–15
- FDA Warns Against Use of Energy-Based Devices to Perform Vaginal “Rejuvenation” or Vaginal Cosmetic Procedures: FDA Safety Communication | FDA [Internet]. 2018 [cited 2019 Dec 13]. //www.fda.gov/medical-devices/safety-communications/fda-warns-against-use-energy-based-devices-perform-vaginal-rejuvenation-or-vaginal-cosmetic
- Hillard TC. Turning the spotlight on lasers. Climacteric 2017;20:397–9
- Digesu GA, Tailor V, Preti M, et al. The energy based devices for vaginal "rejuvenation," urinary incontinence, vaginal cosmetic procedures, and other vulvo-vaginal disorders: An international multidisciplinary expert panel opinion. Neurourol Urodyn 2019;38:1005–8
- Gambacciani M. 'The Comments on Preti et al: "The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: An ICS/ISSVD best practice consensus document". Neurourol Urodyn 2019;38:2010–11
- Bhide AA, Khullar V, Swift S, Digesu GA. The use of laser in urogynaecology. Int Urogynecol J 2019;30:683–92
- Toozs-Hobson P, Toozs-Hobson N, Kelley T. Big data: Why ignorance is no longer acceptable. Int Urogynecol J 2018;29:1235–7
- Gambacciani M, Torelli MG, Martella L, et al. Rationale and design for the Vaginal Erbium Laser Academy Study (VELAS): an international multicenter observational study on genitourinary syndrome of menopause and stress urinary incontinence. Climacteric 2015;18(Suppl 1):43–8